Silicon Valley Learns to Think Inside the Box
Late last year, the Food and Drug Administration decided to take down a rapidly growing Silicon Valley startup called 23andMe Inc., a personal genomics and biotechnology company backed in part by Google Ventures and Russian venture capitalist Yuri Milner. The FDA ordered 23andMe to stop marketing health results from its genetic information product after a lengthy colloquy with the company that (according to the agency) lasted four years and included dozens of meetings, written communications and hundreds of e-mail exchanges.
To continue reading this article you must be a Bloomberg Professional Service Subscriber.
If you believe that you may have received this message in error please let us know.
- Trump Falls on Ceremony. He Should Stop Trying.
- Who Has the World's No. 1 Economy? Not the U.S.
- Richard Spencer Has Only Himself to Blame for Hecklers
- Sorry, President Trump. You're No Chester A. Arthur.
- Russia Is Using Marxist Strategies, and So Is Trump
- Trump's Numbers Are Really, Really Bad
- Nafta Gets a Welcome Reprieve